Skip to Content

Join the 'Herceptin' group to help and get support from people like you.

Herceptin News

FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin

Posted 8 hours ago by Drugs.com

INCHEON, South Korea & JERUSALEM--(BUSINESS WIRE) December 14, 2018 --Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Herzuma (trastuzumab-pkrb), a HER2/neu receptor antagonist biosimilar to Herceptin®1 (trastuzumab) for the following indications: Adjuvant Breast Cancer of HER2 overexpressing node positive or ...

Kadcyla Halves Tumor Recurrence for Women With a Common Breast Cancer

Posted 14 days ago by Drugs.com

WEDNESDAY, Dec. 5, 2018 – For certain women with early stage breast cancer, a newer drug that combines an antibody with chemotherapy may cut the risk of disease recurrence in half, a new trial finds. The study focused on nearly 1,500 women with early stage breast cancer that was HER2-positive – meaning it carries a protein that promotes cancer growth. About one in every five breast cancers is ...

Heart Monitoring a Must for Breast Cancer Patients on Herceptin

Posted 7 Aug 2018 by Drugs.com

TUESDAY, Aug. 7, 2018 – The widely used chemotherapy drug trastuzumab (Herceptin) can be life-saving for women with HER2-positive breast cancer, a particularly aggressive form of the disease. But new research now adds to mounting evidence that the treatment can take a toll on the heart, increasing the risk for heart failure. The complication is uncommon, and in many cases, the benefits of the ...

Breast Cancer Patients May Shorten Herceptin Regimen: Study

Posted 17 May 2018 by Drugs.com

WEDNESDAY, May 16, 2018 – For years, the drug Herceptin has helped women with an aggressive form of breast cancer beat the disease. But there's one downside: In a minority of cases, the drug can trigger heart damage. Now, a new study finds that women who need the drug might get away with taking a shorter, less toxic course of Herceptin. "This new trial shows that a shorter length of treatment ...

Cutting Chemo Heart Risks for Breast Cancer Patients

Posted 12 Mar 2018 by Drugs.com

MONDAY, March 12, 2018 – Two classes of blood pressure drugs show promise in preventing heart complications caused by chemotherapy for breast cancer, researchers report. One in four women who receives the chemo drug Herceptin develops potentially dangerous heart problems. However, the drug is highly effective at treating an aggressive form of breast cancer called HER2-positive, the scientists ...

FDA Approves 'Biosimilar' Drug Ogivri for Breast, Stomach Cancers

Posted 6 Dec 2017 by Drugs.com

FRIDAY, Dec. 1, 2017 – Ogivri (tastuzumab-dkst) has been approved by the U.S. Food and Drug Administration as the nation's first biosimilar drug to treat certain breast and stomach cancers, the agency said Friday in a news release. The maker of a biosimilar, derived from a living organism, must demonstrate that the new product is "highly similar" to an already approved medication, and that it ...

FDA Approves Ogivri (trastuzumab-dkst), a Biosimilar to Herceptin

Posted 5 Dec 2017 by Drugs.com

December 1, 2017 – The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+). Ogivri is the first biosimilar approved in the U.S. for the treatment of breast ...

Do Rising Cancer Drug Prices Warrant Regulation?

Posted 1 Nov 2017 by Drugs.com

WEDNESDAY, Nov. 1, 2017 – Cancer drug prices in the United States keep rising steadily, a new study says. "Regardless of competition or supplemental indications, our study found that there is a steady increase in costs of patented anticancer drugs over time," wrote the researchers. They included Dan Greenberg, an associate professor at Ben-Gurion University of the Negev in Israel. "We believe ...

Speed Up the 'Cancer Moonshot,' Doctors Urge

Posted 1 Nov 2017 by Drugs.com

TUESDAY, Oct. 31, 2017 – The Cancer Moonshot Initiative now has a detailed road map designed to cram a decade's worth of medical advancement into half that time. A new report, authored by more than 50 leading U.S. cancer doctors, highlights 13 priority areas for improving the medical response to cancer, along with measurable goals and a specific timeline for meeting each of those objectives. The ...

Many Cancer Patients Skimp on Treatment Due to Cost

Posted 24 Oct 2017 by Drugs.com

TUESDAY, Oct. 24, 2017 – The high cost of cancer care in the United States has led more than one-quarter of patients to cut back on some part of their treatment, a new survey reveals. Commissioned by the American Society of Clinical Oncology (ASCO), the report found that 27 percent of cancer survivors or close relatives of a cancer patient said they'd skipped doctor visits or taken other steps ...

Alternative Medicine Alone as Cancer Treatment Linked to Lowered Survival

Posted 17 Aug 2017 by Drugs.com

THURSDAY, Aug. 17, 2017 – People who choose alternative medicine over traditional cancer treatments for curable cancers have a higher risk of dying early, researchers report. "We now have evidence to suggest that using alternative medicine in place of proven cancer therapies results in worse survival," said study lead author Dr. Skyler Johnson from Yale School of Medicine and Yale Cancer Center. ...

Treatment Costs Can Be Another Blow to Cancer Patients

Posted 27 Jul 2017 by Drugs.com

THURSDAY, July 27, 2017 – The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research reveals. "The current health law has greatly improved access to meaningful health coverage for cancer patients, survivors and all those with chronic diseases," Chris ...

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 19 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In ...

Most Breast Cancer Patients Have Help Choosing Treatments

Posted 10 Jul 2017 by Drugs.com

MONDAY, July 10, 2017 – Most women who've been diagnosed with breast cancer don't go it alone. Many breast cancer patients depend on family and friends to help them make treatment decisions, get to doctor appointments and seek out other resources. A new study finds half of women rely on three or more people to help them through it. "People just diagnosed with cancer are often scared and ...

FDA Widens Access to 'Cooling Cap' to Stop Hair Loss in Cancer Patients

Posted 5 Jul 2017 by Drugs.com

WEDNESDAY, July 5, 2017 – More cancer patients may be able to ward off hair loss during chemotherapy treatment. A cooling cap approved in 2015 for use in breast cancer patients has won expanded approval from the U.S. Food and Drug Administration. The DigniCap Cooling System can now be used for patients with solid tumors, the FDA announced. The computer-controlled cap contains liquid that ...

Page 1 2 3 4 Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer - Adjuvant, Breast Cancer, Breast Cancer, Metastatic, Esophageal Carcinoma, Gastric Cancer, Salivary Gland Cancer

Herceptin Patient Information at Drugs.com